Patents by Inventor Hirohiko Arisawa

Hirohiko Arisawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Agent for preventing and/or treating multiple organ failure
    Patent number: 7306791
    Abstract: The present invention provides methods of preventing and/or treating multiple organ failure comprising the step of administering a therapeutically effective amount of agent comprising tumor cytotoxic factor-II (TCF-II) or hepatocyte growth factor (HGF). Methods of the present invention will be useful for preventing and/or treating the development of multiple organ failure resulting from burn, disseminated intravascular coagulation (DIC), circulatory failure, hemorrhagic shock, infectious disease, acute pancreatitis, ischemic disorder, hepatorenal syndrome, gastrointestinal hemorrhage, nutritional metabolic failure, terminal cancer, acquired immunodeficiency syndrome (AIDS), deterioration of systemic conditions due to radiation affection, and cachexia.
    Type: Grant
    Filed: December 11, 2002
    Date of Patent: December 11, 2007
    Assignee: Daiichi Sankyo Co., Ltd.
    Inventors: Hirohiko Arisawa, Hiroaki Masunaga, Hiromi Ogawa, Kanji Higashio
  • Agent for preventing and/or treating multiple organ failure
    Publication number: 20030153489
    Abstract: The present invention is to provide an agent for preventing and/or treating multiple organ failure comprising Tumor cytotoxic factor-II (TCF-II) or Hepatocyte growth factor (HGF) as an effective ingredient.
    Type: Application
    Filed: December 11, 2002
    Publication date: August 14, 2003
    Inventors: Hirohiko Arisawa, Hiroaki Masunaga, Hiromi Ogawa, Kanji Higashio
  • Dry skin remedies
    Patent number: 6410557
    Abstract: Novel dry skin remedies useful for treatment dry skin, containing as the active ingredient spiro [oxathiolane-quinuclidine] derivatives represented by general formula (I) or acid addition salts thereof, desirably cis-2-methylspiro [1,3-oxathiolane-5,3′-quinuclidine] hydrochloride. The remedies promote the secretion of sebaceous and sweat glands through oral or parenteral administration to treat dry skin, thus being useful as drugs.
    Type: Grant
    Filed: July 5, 2001
    Date of Patent: June 25, 2002
    Assignee: Daiichi Pharmaceutical Col, Ltd.
    Inventors: Keiji Hayashi, Hirohiko Arisawa, Hiroaki Masunaga
  • Dry skin remedies
    Publication number: 20020004056
    Abstract: Novel dry skin remedies useful for treatment dry skin, containing as the active ingredient spiro [oxathiolane-quinuclidine] derivatives represented by general formula (I) or acid addition salts thereof, desirably cis-2-methylspiro [1,3-oxathiolane-5,3′-quinuclidine] hydrochloride. The remedies promote the secretion of sebaceous and sweat glands through oral or parenteral administration to treat dry skin, thus being useful as drugs.
    Type: Application
    Filed: July 5, 2001
    Publication date: January 10, 2002
    Inventors: Keiji Hayashi, Hirohiko Arisawa, Hiroaki Masunaga
  • AGENT FOR PREVENTING AND/OR TREATING MULTIPLE ORGAN FAILURE
    Publication number: 20010051146
    Abstract: The present invention is to provide an agent for preventing and/or treating multiple organ failure comprising Tumor cytotoxic factor-II (TCF-II) or Hepatocyte growth factor (HGF) as an effective ingredient.
    Type: Application
    Filed: August 27, 1999
    Publication date: December 13, 2001
    Inventors: HIROHIKO ARISAWA, HIROAKI MASUNAGA, HIROMI OGAWA, KANJI HIGASHIO